Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1Condition 2Condition 3aCondition 3b
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.erythrocyte quantityRS:0000742WKYmale0 days11CMO:0000037hematocrit45.2%1.44.6433MMO:0000214hematocrit analysis0.0unx168daysunilateral nephrectomy (for 28 days) then vehicle control condition99975unilateral nephrectomy (for 28 days)vehicle control condition
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.erythrocyte quantityRS:0000742WKYmale0 days17CMO:0000037hematocrit44.8%0.62.4739MMO:0000214hematocrit analysis0.0unx168daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition99976unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) vehicle control condition
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.erythrocyte quantityRS:0000742WKYmale0 days17CMO:0000037hematocrit45.6%0.31.2369MMO:0000214hematocrit analysis0.0unx168daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days)99977unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) bosentan (100 mg/kg/d) (for 154 days)
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.erythrocyte quantityRS:0000742WKYmale0 days16CMO:0000037hematocrit45.8%0.52.0MMO:0000214hematocrit analysis0.0unx168daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days)99978unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) enalapril (10 mg/kg/d) (for 154 days)
2378Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.erythrocyte quantityRS:0000742WKYmale0 days16CMO:0000037hematocrit44.5%0.62.4MMO:0000214hematocrit analysis0.0unx168daysunilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days)99979unilateral nephrectomy (for 28 days)streptozotocin (35 mg/kg) enalapril (10 mg/kg/d) (for 154 days)bosentan (100 mg/kg/d) (for 154 days)
2479Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.erythrocyte quantityRS:0000742WKYmale0 days9CMO:0000037hematocrit41%1.03.0MMO:0000214hematocrit analysis0.00.9% sodium chloride solution (3 ml) 1004360.9% sodium chloride solution (3 ml)
2479Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.erythrocyte quantityRS:0000742WKYmale0 days7CMO:0000037hematocrit39%1.02.6458MMO:0000214hematocrit analysis0.0PA IV 50mg/kg23dayspuromycin aminonucleoside (50 mg/kg) 100437puromycin aminonucleoside (50 mg/kg)
2479Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.erythrocyte quantityRS:0000742WKYmale0 days5CMO:0000037hematocrit35%1.02.2361MMO:0000214hematocrit analysis0.0PA IV 50mg/kg23dayscontrolled enalapril content drinking water (50 mg/l) (for 30 days) then puromycin aminonucleoside (50 mg/kg) 100438controlled enalapril content drinking water (50 mg/l) (for 30 days)puromycin aminonucleoside (50 mg/kg)
2479Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.erythrocyte quantityRS:0000742WKYmale0 days8CMO:0000037hematocrit45%1.02.8284MMO:0000214hematocrit analysis0.00.9% sodium chloride solution (3 ml) 1004390.9% sodium chloride solution (3 ml)
2479Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.erythrocyte quantityRS:0000742WKYmale0 days9CMO:0000037hematocrit43%1.03.0MMO:0000214hematocrit analysis0.0PA IV 50mg/kgpuromycin aminonucleoside (50 mg/kg) 100440puromycin aminonucleoside (50 mg/kg)
2479Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.erythrocyte quantityRS:0000742WKYmale0 days8CMO:0000037hematocrit43%1.02.8284MMO:0000214hematocrit analysis0.0PA IV 50mg/kgcontrolled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) 100441controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days)puromycin aminonucleoside (50 mg/kg)
2479Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.erythrocyte quantityRS:0000742WKYmale0 days9CMO:0000037hematocrit44%1.03.0MMO:0000214hematocrit analysis0.00.9% sodium chloride solution (3 ml) 1004420.9% sodium chloride solution (3 ml)
2479Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.erythrocyte quantityRS:0000742WKYmale0 days8CMO:0000037hematocrit44%1.02.8284MMO:0000214hematocrit analysis0.0PA IV 50mg/kg490dayspuromycin aminonucleoside (50 mg/kg) 100443puromycin aminonucleoside (50 mg/kg)
2479Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.erythrocyte quantityRS:0000742WKYmale0 days9CMO:0000037hematocrit42%1.03.0MMO:0000214hematocrit analysis0.0PA IV 50mg/kg490dayscontrolled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) 100444controlled enalapril content drinking water (50 mg/l) (for 497 days)puromycin aminonucleoside (50 mg/kg)